The intersection of radiopharmaceuticals and nanotechnology has propelled the field of medicine forward, particularly concerning targeted cancer therapies.
Understanding what vulnerabilities exist, along with their potential severity and impact, can dramatically strengthen an organization’s cybersecurity posture and improve overall cyberreadiness.